by Rupa Palanki
In May 2024, a bipartisan group of female senators introduced the Advancing Menopause Care and Mid-Life Women’s Health Act. The bill allocates $275 million over five years toward strengthening and expanding federal research, health care provider training, and public health education on menopause and mid-life women’s health issues. If enacted, it would be the most comprehensive federal effort to improve health care related to menopause. However, further action related to the labeling of low-dose estrogen and workplace support is still necessary to support individuals experiencing menopause.
Unmet Needs for Legislative and Policy Action
Menopause is the natural stage of life when an individual has not had a menstrual period for twelve consecutive months, signifying the end of their fertile years. Half of the American population will eventually experience this transition. Currently, 75 million American individuals are either in menopause, perimenopause (the time before menopause when menstrual cycles may become irregular), or postmenopause (when an individual has not had a menstrual period for longer than a year). Another 6,000 reach menopause daily. Read More